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KESAN PROTEIN KERAS KORONA PADA NANOPARTIKEL QD 
TERHADAP SEL PENUAAN 
 
ABSTRAK 
Perubatan nano merupakan bidang kajian penting yang mengkaji penggunaan 
bahan nano dan nanopartikel dalam terapi perubatan dan tujuan diagnostik. 
Walaubagaimanapun, tidak banyak kajian yang menumpukan pada aspek penuaan yang 
berkaitan dengan nanomedikal yang mungkin berguna untuk merawat penyakit yang 
berkaitan dengan penuaan seperti sindrom Werner, sarcopenia dan Alzheimer. Dalam 
kerja ini, potensi sitotoksik titik kuantum (QD-PEG) dan QD-PEG bersalut protein keras 
corona (QD-HC) pada sel-sel yang berbeza umur diperiksa. Pada fasa awal kajian, 
interaksi QD dengan protein dari plasma darah manusia dianalisis. Keputusan telah 
menunjukkan bahawa corona protein dapat membentuk pada QD-PEG berdasarkan 
analisis SDS-PAGE, MALDI-TOF/TOF, LC-MS/MS dan μBCA. Pembentukan corona 
protein keras mengubahsuai sifat fizikokimia QD-PEG berdasarkan analisis TEM, AFM, 
DLS dan potensi zeta. Telah ditentukan bahawa perubahan kepada sifat-sifat fiziokimia 
telah menjejaskan keupayaan koloid QD-PEG secara signifikan. Pada tahap berkadar 
konsentrasi nanopartikel, corona protein keras telah memberi ciri-ciri fotonik dan koloid 
yang unik kepada QD-PEG yang lebih bersesuaian untuk aplikasi nanomedikal dari segi: 
(1) dipertingkatkan kestabilan fotonik dalam keadaan pH yang terlampau, (2) rintangan 
yang lebih besar kepada perubahan dalam medium extracellular yang mendorong 
penumpuan dan pemendapan graviti, dan (3) meningkatkan keteguhan QD-PEG daripada 
kemusnahan dan larut lesap bahan terasnya dalam keadaan pH yang terlampau. Dalam 
fasa kedua kajian, kaedah penuaan yang berbeza telah digunakan untuk 
xix 
 
membangunkan model senescent sel fibroblast (IMR90) dan sel epitelium 
(CCD841CoN). Hasilnya telah menunjukan bahawa model senescent untuk sel IMR90 
dan sel CCD841CoN telah berjaya dibangunkan. Dalam fasa akhir kajian ini, potensi 
sitotoksik daripada QDs pada sel-sel muda dan uzur dinilai menggunakan ujian WST-1, 
NRR dan LDH. Keputusan daripada kajian menunjukkan bahawa QDs tidak akut toksik 
kepada sel muda IMR90 dan sel muda CCD841CoN. Sebaliknya, QDs memberi kesan 
toksik kepada sel-sel senescent IMR90 dan CCD841CoN dengan tahap yang berbeza pada 
masa pendedahan yang sama. Data telah menunjukkan bahawa kesan toksik QD-PEG 
telah menyebabkan kematian nekrotik kepada sel senescent IMR90 dan CCD841CoN 
melalui permeabilisasi membran lysosom dalam tempoh 24 jam inkubasi. Sel-sel 
senescent mempunyai tindak balas yang berbeza terhadap kesan-kesan toksik disebabkan 
oleh QD-HC bergantung kepada kepekatannya. Pada kepekatan QD-PEG yang sama, 
QD-HC telah menyebabkan kematian sel senescent IMR90 dan CCD841CoN melalui 
autophagy; manakala pada kepekatan QD-HC yang lebih tinggi, kematian sel secara 
nekrotik melalui permeabilisasi membran lysosom diperhatikan dalam tempoh 24 jam 
inkubasi. Penemuan kajian ini akan memberi manfaat kepada para penyelidik dalam 
bidang perubatan nano untuk merancang eksperimen mereka dengan lebih berkesan 
selepas menyesuaikan pengaruh protein korona dan perbezaan usia dalam kajian yang 
memaparkan sistem penyampaian ubat berasaskan nanopartikel yang ditujukan kepada 






THE EFFECT OF HARD PROTEIN CORONA ON QD NANOPARTICLE 
TOWARDS SENESCENT CELLS  
 
ABSTRACT 
Nanomedicine is an important area of study that examines the utilization of 
nanomaterials and nanoparticles in medical therapy and diagnostic purposes. However, 
not many studies have focused on the aging related aspect of nanomedical research that 
could have been valuable in treating aging associated diseases such as Werner syndrome, 
sarcopenia and Alzheimer’s. In the present work, the cytotoxic potential of PEGylated 
quantum dots (QD-PEG) and hard protein corona coated QD-PEG (QD-HC) on cells of 
opposing age groups were examined. In the initial phase of the study, the interaction of 
QDs with proteins from human blood plasma were analyzed. The results have shown that 
protein corona was able to form on pristine QD-PEG based on SDS-PAGE, MALDI-
TOF/TOF, LC-MS/MS and µBCA analysis. Formation of hard protein corona had 
transformed its physicochemical properties, which had in turn affected the colloidal 
stability of QD-PEG in a significant manner. At proportionate levels of nanoparticle 
concentration, hard protein corona had imbued distinct photonic and colloidal 
characteristics to QD-PEG that were better suited for nanomedical applications in terms 
of: (1) enhanced photostability at extreme pH conditions, (2) greater resistance to changes 
in extracellular medium that induces agglomeration and gravitational sedimentation, and 
(3) increased robustness to degradation and leaching of QDs’ core materials at extreme 
pH conditions. In the second phase of the study, different aging methods were employed 
to develop senescent models of fibroblast (IMR90) and epithelial (CCD841CoN) cells. 
Based on the benchmarks established in the current experiment, senescent models for 
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IMR90 and CCD841CoN cells were successfully developed. In the final phase of the 
study, the cytotoxic potential of the QDs on young and senescent cells were assessed and 
results from the study have demonstrated that the QDs were not acutely toxic on the 
former. In contrast, the QDs were lethal to senescent cells of both types with varying 
degree at the same exposure time. The data have shown that QD-PEG were acutely toxic 
to senescent IMR90 and CCD841CoN cells, leading to lysosomal membrane 
permeabilization induced necrotic cell death. The senescent cells had divergent response 
to the toxic effects induced by QD-HC depending on its concentration. At similar 
concentration of QD-PEG, QD-HC had induced autophagic cell death due to cadmium 
toxicity and halved the senescent cell population; while, at much higher concentrations of 
QD-HC, lysosomal membrane permeabilization induced necrosis was observed, resulting 
in total death of senescent cell population. At all instances, the common denominator was 
the disruption to the lysosomal activity of senescent cells preceding the loss of its viability. 
Incidentally, QD disintegration within the lysosomal compartment was determined to be 
the precursor event leading up to the binary cell deaths. The rate of QD disintegration was 
the determining factor for the mode of cell death and protein corona was found to effect 
this process significantly. Deeper introspection has led to the discovery that protein corona 
had delayed the QDs’ disintegration and consequently had attenuated its cytotoxic 
potential. The susceptibility of senescent cells to the toxic effects of QDs were attributed 
to the deterioration of its organelles and disruption in cellular functions relative to the 
young phenotype. The current findings will benefit researchers in the field of 
nanomedicine to design their experiments more effectively after adjusting for protein 
corona influences and age related differences in studies featuring nanoparticle based drug 
delivery systems geared towards therapeutic or clinical applications. 
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CHAPTER ONE: INTRODUCTION 
1.1 Overview and rationale of the study 
The field of nanomedicine is expanding at an astounding rate largely due to the 
amalgamation of technology from other emerging fields such as nanotechnology, 
biotechnology and bioconjugation chemistry. The core component of this innovative 
technology is nanoparticle and its subsequent utility as therapeutic and diagnostic agents 
in clinical applications makes it an active area of research.  
 
Quantum dots (QDs) are a class of nanoparticle that are widely being used in the 
biomedical field for diagnostic and imaging applications. Controlled illumination, 
enhanced resolution and greater resistance to photobleaching relative to the conventional 
stains are some of the qualities that made QDs an invaluable tool in live imaging of small 
animals and humans. The delivery of these QDs were mostly administered intravenously 
at the target site and tracked throughout the circulatory system in the body. As a 
consequence, the QDs will encounter blood plasma proteins that adsorb onto the 
circulating nanoparticles either reversibly or irreversibly depending on the affinity of the 
proteins to the nanoparticle. This phenomenon of protein adsorption is known as ‘The 
Vroman Effect’ and the adsorbing proteins are denoted as protein corona (Lesniak et al., 
2012; Mahmoudi, 2018). Ultimate manifestation of the interaction between these two 
entities is the modification of QD’s physicochemical properties. This is an undesirable 
outcome as the QDs are essentially tailored to perform specific functions such as targeted 
entry into the cells and even targeted sites within the cells or organelles. As such, methods 
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to circumvent this effect or incorporate it as part of the delivery strategy will greatly 
benefit in increasing the targeting yield and efficacy of the QDs while inadvertently 
improving its imaging resolution. In the first phase of this study, the interaction of QDs 
with proteins from human blood plasma were analysed.   
 
Another serious consideration when administering QDs to living organisms are its 
toxic effects on the cell, which creates a potential liability for its use. QDs can be toxic to 
cells due to intrinsic factors such as its core chemical composition, surface chemistry, size 
distribution and colloidal stability. To study the toxic effects and optimize the parameters 
for safe administration of QDs, in vitro cellular models can be utilized. These in vitro 
models are useful tools to quantitatively study the toxic effect of nanoparticles on different 
types of cultured cells. Apart from the potential of QDs to induce deleterious effects on 
the cells, the cellular model selected for cytotoxicity evaluation may have an impact on 
the final outcome of the study.  
 
Some of the cellular models that were typically employed for cytotoxicity testing 
of nanoparticles are fibroblast, epithelial, endothelial, macrophage, cancer and stem cells. 
The prerequisite for selecting the in vitro cellular models is to ideally represent the in vivo 
conditions. However, the age of the cell is an overlooked factor in many studies and the 
interaction of nanoparticles with ageing cells were rarely addressed, if any in the 
cytotoxicity studies. By using senescent cell models along with the non-senescent cells of 
similar genotype, the conclusion of the study will epitomize heterogeneity and reduced 
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biasness. Therefore, age related studies will provide a more comprehensive understanding 
of nanoparticle toxicity as it reflects the diversity in the general population. In the second 
phase of the study, senescent models of fibroblast and epithelial cells were developed 
using established cell ageing methods to assess the cytotoxic potential of QDs.   
 
Principal goal of the current study was to gauge the effect of protein corona 
formation on QDs and its subsequent correspondence with cells of different age groups in 
an in vitro setting. Thus, the two tiered experimental approach discussed above were 
integrated in the final part of the study and the resulting data were meticulously evaluated.  
 
1.2 Research objectives  
The current study was undertaken with the following objectives:  
1. To characterize and evaluate the impact of hard protein corona on the 
physicochemical properties of the quantum dots.    
2. To establish in vitro senescent cell models using fibroblast (IMR90) and epithelial 
(CCD841CoN) cells.  
3. To determine the interaction and cytotoxic potential of pristine and hard corona 
coated quantum dots on young and senescent cells. 
4. To investigate the modality and mechanism of senescent cell death induced by the 




1.3 Flow chart of the study  
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CHAPTER TWO: LITERATURE REVIEW 
2.1 Nanoparticles   
2.1.1 Characteristics of nanoparticle  
Nanoparticles (NPs) are defined as particles with all its three dimensions confined 
within the range of 1 to 100 nm (Albanese et al., 2012; Docter et al., 2015a; Bhatia, 2016). 
The growing attention to NP stem from the fact that their mechanical, chemical, optical 
electrical, and magnetic properties differs to those of bulk counterparts and these 
properties can be altered by varying the size (Mahmoudi et al., 2011a; Rahman et al., 
2013). Due to their capability of tuning properties for intended requirements, NPs are of 
significant interest in different fields such as physics, chemistry, engineering, electronics, 
and biology (Aggarwal et al., 2009; Mahmoudi et al., 2011a; Kharazian et al., 2016; 
Schöttler et al., 2016). Nanoparticles can be made of inorganic materials like gold, silica, 
iron oxide, or made of organic polymers including polystyrene (PS), poly (lactic-co-
glycolic acid) (PLGA) and polylactic acid (PLA) (Schöttler et al., 2016).  
 
2.1.2 Nanoparticles in biomedical application  
The utilization of NPs in biomedical application arise from their inherent 
properties of small size and high surface to volume ratio (Chinen et al., 2015; Smith et al., 
2015). Small size of NP enables them to translocate cross biological barriers and reach 
subcellular compartment, biological components and those targets that were not possible 
to access previously such as brain (Saptarshi et al., 2013; Caracciolo et al., 2016). In 
particular, NPs smaller than 100 nm are able to enter the cells, smaller than 40 nm enter 
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nucleus of the cells and less than 35 nm can across the blood brain barrier (Dawson et al., 
2009). Moreover, high surface to volume ratio of NP make them highly active and more 
efficiently in interactions with biological component than that of bulk counterpart 
(Karmali and Simberg, 2011; Westmeier et al., 2015; Polyak and Cordovez, 2016). These 
interesting properties of nanoparticles make them as a promising multifunctional tool in 
different medical applications (Docter et al., 2015a). 
 
Nanoparticles are increasingly considered to employ in medical imaging, drug 
delivery, diagnostic, and hyperthermic therapy purposes (Rahman et al., 2013; 
Mahmoudi, 2016). Likewise, nanoparticles are highly potential to use as contrast agent in 
magnetic resonance imaging (MRI), fluorescence spectroscopy and optical imaging 
(Seeney et al., 2012; Hou et al., 2013; Rizzo et al., 2013; Westmeier et al., 2015). Metal 
oxides have begun to use in magnetic resonance imaging in 1970s (Rahman et al., 2013). 
Magnetic nanoparticles have been widely used in magnetic resonance imaging, magnetic 
particle imaging and magnetic drug targeting as well as in hyperthermia application 
(Krishnan, 2010; Gräfe et al., 2016). Plasmonic particles such as gold (Au) and silver (Ag) 
are employed for optical imaging along with laser induced photothermal therapy (de 
Aberasturi et al., 2015). 
 
Nanoparticles have demonstrated promising features for the delivery of 
therapeutic drugs to the target site of body (Mirshafiee et al., 2013). In contrast to micron-
sized particles that rapidly eliminated by immune system, nanoparticles in drug delivery 
system can be delivered to all organs (Mause and Weber, 2010; Rak, 2010; Lee et al., 
2015). Moreover, NP-based drug delivery shows higher solubility, improved 
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pharmacokinetics, reduced toxicity, greater biodistribution and increased drug 
bioavailability which result in fewer side effects and enhancing therapeutic index of drugs 
(Pautler and Brenner, 2010; Wahajuddin, 2012; Polyak and Cordovez, 2016). 
 
Administration of NP in drug delivery has opened up new opportunities in cancer 
therapy (van der Meel et al., 2013; Pearson et al., 2014a). Encapsulation of drugs in 
nanoparticles carrier or nanocapsules have been introduced in cancer therapy as a new 
promising approach (Albanese et al., 2012; Salvati et al., 2013; Mirshafiee et al., 2016a). 
Severe side effects that cause by chemotherapeutic drugs due to their high cytotoxicity 
can be diminished by utilizing nanocarriers. Among chemotherapeutic drugs doxorubicin 
and paclitaxel were the first drugs which was administrated by nanocarriers (Schöttler et 
al., 2016). 
 
Numerous nanotherapeutics have already acknowledged clinical approval and 
several others are currently going through clinical trials (Wolfram et al., 2014). Thus, due 
to increase application of nanoparticles in nanomedicine, it is crucial to understand their 
interaction with biological compartment and consequent physiological response to ensure 
the safe and efficient implementation of nanomedicine (Nel et al., 2009; Mahmoudi et al., 






2.2 Nanoparticle protein-corona complex 
Due to their large surface to volume ratio, nanoparticles in biological medium tend 
to lower their high surface energy by interacting with medium components (Monopoli et 
al., 2011a; Wolfram et al., 2014; Polyak and Cordovez, 2016; Westmeier et al., 2016). 
Therefore, when NP is dispersed in biological medium physical and chemical interactions 
arise, leading to formation of new interface between NP and biological component called 
“bio-nano interface” which is merging of organic and synthetic worlds (Mahmoudi et al., 
2011a; Treuel and Nienhaus, 2012; Gunawan et al., 2014; Schöttler et al., 2016). It is now 
well accepted that upon introduction of NP to biological environment, variety of proteins 
would cover the surface of NP forming a layer, called “protein corona” (Treuel, 2013; 
Pearson et al., 2014b; Pozzi et al., 2015; Corbo et al., 2016; Mahmoudi, 2016). 
 
It is noteworthy to mention that it is protein corona that primarily interact with 
biological component rather than the pristine surface of NP. In particular, protein corona 
constitute what the biological system actually sees when encounter the NP (Brun and 
Sicard–Roselli, 2014; Docter et al., 2015b; Liu et al., 2015; Serpooshan et al., 2015; 
Caracciolo et al., 2016) (Figure 2.1). Protein corona changes the interfacial properties of 
NP endowing it new identity termed biological identity which is significantly different 
from its synthetic identity. More specifically, protein corona transforms the synthetic 
identity of NP to biological identity, making the nanoparticle- protein corona complex to 
be seen as one entity (Monopoli et al., 2012; Hadjidemetriou et al., 2015; Maiolo et al., 




This is the biological identity that mediate the interaction with membrane and 
biological barriers, determining the subsequent physiological responses including cellular 
uptake, kinetics, transport, biodistribution, signalling, and toxicity of the nanoparticles 
(Saptarshi et al., 2013; Kelly et al., 2015; Lee et al., 2015; Mahmoudi et al., 2015; Wan 
et al., 2015; Kharazian et al., 2016). Thus deep understanding of nanoparticle-protein 
corona complex and its biological implications is a vital step toward safe design of 
nanoparticle in medical application. 
 
 
Figure 2.1: The nanoparticle–corona complex in a biological environment. (a) It is the 
nanoparticle–corona complex, rather than the bare nanoparticle, that interacts with 
biological machinery, here with a cell membrane receptor. (b) Relevant processes 
(arrows), in both directions (on/off), for a nanoparticle interacting with a receptor. 
Adapted from  (Monopoli et al., 2012).  
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2.2.1 Composition of the protein-corona 
The identities of proteins in corona play a key role in defining the physiological 
response to NP- protein corona complex. Although, more than 3,700 proteins in the blood 
plasma compete for binding to the surface of nanoparticle, their abundance in the plasma 
is not related to their abundance in the protein corona. Furthermore, they are not merely 
those with the highest affinity for the surface of NP (Ge et al., 2011; Martel et al., 2011; 
Zhang et al., 2011a; Dufort et al., 2012; Monopoli et al., 2012). It is noteworthy to mention 
that there is no universal protein corona for all nanoparticle and composition of protein 
corona is unique to each nanoparticle (Walkey and Chan, 2012). 
 
Walkey and Chan established a trend in composition of protein corona by 
compiling a list of identified proteins for 63 nanomaterials across numerous studies. They 
have identified the total of 125 plasma proteins in protein coronas, demonstrating a subset 
of plasma proteins which adsorb at least to one nanomaterial, termed ‘adsorbome’. A 
similar trend was observed for all protein coronas in which 2 to 6 proteins for each 
nanomaterial were adsorbed abundantly, and other adsorbed proteins were low abundance 
proteins. The proteins that adsorb at high abundance to some nanomaterial are not the 
same abundant proteins to another. Some proteins may adsorb at high abundance to some 
nanomaterial but the same proteins adsorb on others with low abundance. They have 
classified adsorbed blood proteins to two groups; one is included of those proteins that 
have the capability to adsorb at high abundance to nanomaterial surface but it does not 
necessarily occur, and another one including of plasma proteins that can only adsorbed at 
low abundance (Walkey and Chan, 2012). 
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One protein group which has been extensively identified in protein corona of 
different nanoparticles is apolipoproteins. This protein which is part of lipoprotein 
complex, their main role is transporting lipids and cholesterol through the bloodstream 
(Lynch and Dawson, 2008; Monopoli et al., 2012; Gunawan et al., 2014). Adsorption of 
apolipoproteins on nanoparticles surface lead to interact with lipoprotein receptors on the 
cell surface (Wagner et al., 2012; Saptarshi et al., 2013; Tenzer et al., 2013). This 
characteristic has been exploited to transport the drugs cross the blood–brain barrier 
(BBB), and reach the central nervous system (CNS) to treat CNS diseases such as 
Alzheimer's and Parkinson's diseases (Aggarwal et al., 2009; Monopoli et al., 2012; 
Walkey and Chan, 2012; Gunawan et al., 2014). 
 
Another group of protein that is often recognized in corona profile are complement 
proteins. This group of proteins are part of innate immune system that helps eliminating 
the pathogen from the body. The complement system which consist of more than 30 
proteins tag the pathogen to be recognized by phagocyte (Tenzer et al., 2011; Schöttler et 
al., 2016). Fibrinogen another group of plasma proteins activate proinflammatory 
pathways and it is involved in the formation of blood clot (Deng et al., 2011; Monopoli et 
al., 2011a). 
 
Immunoglobulins is another major component of plasma protein which play a key 
role in the immune system. This type of protein is consisting of five isotypes as follows, 
IgG, IgA, IgM, IgD, IgE.  The smallest isotype of immunoglobulins, IgG is the only 
antibody that is able to across the placenta, and the biggest isotype IgM is the first antibody 
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that react to infection (Sacchetti et al., 2013; Gunawan et al., 2014). Aggarwal et alhas 
been reported that  apolipoprotein, complement proteins, fibrinogen and immunoglobulins 
exist in the protein corona of almost any NP (Aggarwal et al., 2009). 
 
Adsorption of certain subset of proteins on the surface of nanoparticles enhance 
the uptake by macrophages cells of the reticuloendothelial system (RES). This category 
of proteins which is called opsonins is included of IgG, complement factors, and 
fibrinogen. Binding of opsonins to nanoparticles make a “molecular signature” for 
immune system, causing clearance from blood circulation and accumulation in the liver 
and spleen (Aggarwal et al., 2009; Walkey and Chan, 2012; Pearson et al., 2014b; Lee et 
al., 2015).  
 
Karmali and Simberg reviewed the identity of corona profile on different 
nanoparticles. They have concluded that on liposomes and polymeric nanoparticles, 
apolipoproteins are the main group of proteins that adsorb on the surface of nanoparticles, 
but this does not imply for inorganic nanoparticles. By reducing hydrophobicity of 
polymeric nanoparticles, the adsorption of ApoA-I, ApoA-IV, ApoC-III and ApoJ was 
decreased, while there was no change in the absorption level of IgG and albumin. Albumin 
had strong affinity for cationic lipoplexes and polyplexes as well as hydrophobic surfaces.  
The protein profile on hydrophilic inorganic nanoparticles significantly differ than 
polymeric nanoparticles with hydrophobic surface. Transferrin, haptoglobin, fetuin A, 
kininogen, histidine-rich glycoprotein, and clotting pathway factors were found on 
hydrophilic inorganic nanoparticles. Absorption of complement C3 was increased by 
presence of hydroxyl group on nanoparticle surface (Karmali and Simberg, 2011). 
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2.2.2 Mechanisms and kinetics of protein adsorption 
Protein corona forms through a dynamic process and adsorbed proteins are in 
constant state of flux. More specifically, protein corona is not a fix layer and proteins on 
NP surface are in continues exchange with free proteins in biological medium (Aggarwal 
et al., 2009; Rahman et al., 2013; Kharazian et al., 2016). Formation of protein corona is 
a time dependent process which it evolves by the time. In particular, the composition of 
protein corona evolve considerably from what was formed at the initial stages due to 
ongoing exchange of high abundance protein which adsorb first with low abundance 
proteins adsorbing to nanoparticles surface afterward (Saptarshi et al., 2013; Gunawan et 
al., 2014; Wan et al., 2015; Corbo et al., 2016; Vilanova et al., 2016).  
 
The time evolution of protein corona formed around gold nanoparticles (AuNPs) 
in the cell culture media with 10% fetal bovine serum (FBS) was studied. The size of 
AuNPs were in the range of 4 to 40 nm and were stabilized with citrate ions, self-
assembled monolayer (SAM) of mercaptoundecanoic acid (negative surface charge) and 
self-assembled monolayer (SAM) of aminoundecanethiol (positive surface charge). By 
increasing the incubation time, an enhancement in the hydrodynamic diameter, decrease 
in the surface charge and the red-shift of surface plasmon resonance was observed. This 
result indicates that the protein corona was evolved from a loosely weakly bound protein 
toward an irreversible persistent protein corona over time (Casals et al., 2010). 
 
The changes occurred over time in corona profile of lecithin-coated polystyrene 
nanosphere were investigated by Nagayama et al. In a liver perfusion study by employing 
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SDS-PAGE and western blotting the protein corona was analysed quantitatively and 
qualitatively in the time period of 5 to 360 minutes. Over time, an increment in the total 
amount of adsorbed proteins on nanoparticles surface was observed. Moreover, there were 
significant changes in the qualitative profile of protein in which complement C3 (C3) and 
immunoglobulin G (IgG) showed enhancement by the time and there was a slight increase 
in apolipoprotein E (ApoE) and immunoglobulin A (IgA). The hepatic uptake by liver 
macrophages (Kupffer cells) was higher over the time indicating increased opsonisation 
of NP (Nagayama et al., 2007). 
 
Protein corona evolves also as NP migrate from one biological compartment to 
another. The final corona retains the memory of its journey within the body. Thus, the 
composition of protein corona depends on all the environments which NP has passed 
through (Milani et al., 2012; Monopoli et al., 2012; Schleh et al., 2012; Maiolo et al., 
2015). This concept can be employed to track the biodistribution of NP which in turn is 
important in nanotherapeutics applications (Gunawan et al., 2014; Hamad-Schifferli, 
2015; Schöttler et al., 2016). 
 
Lundqvist et alstudied protein corona evolution following moving from one 
biological fluid to another. They have simulated in vivo transport by incubating silica, 
polystyrene, and carboxyl-modified polystyrene NPs in human plasma following 
incubating the NPs in cytosolic fluid. The result showed remarkable evolution of the 
protein corona over time but the final corona after second incubation, encompasses the 
“fingerprint” of its history. They suggested that this phenomenon can be utilized to trace 
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the transport pathway of nanoparticle as well as the fate and biological behaviour of NP 
(Lundqvist et al., 2011).  
 
Recently, researchers are applying quantitative models to determine the 
associations between the structure of protein corona and distinctive protein corona 
‘fingerprints’. Chan et alestablished a novel model to predict the biological behaviour of 
nanoparticle. They applied fingerprint of protein corona formed around 105member 
library of surface-modified gold nanoparticles. They concluded that this model was 50% 
more accurate than previous model which utilize physicochemical properties of 
nanoparticle such as size, surface charge and aggregation state (Walkey et al., 2014). 
 
The rate of adsorption /desorption of proteins over time refers as kinetics of protein 
corona. Kinetics rate of each protein determine composition of protein corona at any given 
time. The possibility of the contact between nanoparticle-protein and probability of that 
contact lead to adsorption of protein defined by association constant (kon). As such, 
dissociation constant (koff) represent the binding energy of nanoparticle-protein complex, 
in which the higher the binding energy the lower the dissociation constant. The balance 
between association rates (kon) and dissociation rate (koff) of a protein is defined by binding 
constant (Kd) and indicates which proteins will be bound to the NP surface at equilibrium 
conditions. (Ehrenberg et al., 2009; Dell'Orco et al., 2010; Walkey and Chan, 2012; 




The dynamic process and evolution of proteins on the flat surface was analysed by 
Vroman at 1962 (Vroman, 1962). This researcher explained the complex series of proteins 
displacement by time known as “Vroman Effect” which has been applied to nano-surfaces 
as well. “Vroman Effect” states the identity of proteins adsorbed on the surface varies over 
time although, the total quantity of the adsorbed protein remains constant. (Jansch et al., 
2012; Vogler, 2012; Docter et al., 2015a; Kharazian et al., 2016). This phenomenon which 
depends on the abundance and affinity of the proteins along with their diffusion 
coefficients., is consist of two distinct stages refereed as ‘early’ and ‘late’ stage. During 
the early stage, adsorption of albumin, IgG, and fibrinogen take place which are highly 
motile proteins. These proteins will be then replaced by more static proteins such as 
apolipoproteins and coagulation factors during the late stage (Walkey and Chan, 2012; 
Rahman et al., 2013). Kinetic study on solid lipid nanoparticles (SLN) showed that in the 
early stage albumin was adsorbed which was then replaced by fibrinogen. Over time IHRP 
(inter-α-trypsin inhibitor family heavy chain-related protein) and apolipoproteins 
substitute fibrinogen, indicating being in agreement with “Vroman effect”(Göppert and 
Müller, 2005). 
 
Protein corona on nanoparticles are so thick to be considered as a monolayer of 
proteins but composed of multiple layers like Christmas tree structures (Walkey and Chan, 
2012; Rahman et al., 2013; Docter et al., 2015a; Docter et al., 2015b). Protein corona can 
be classified into two different types of protein layers, an inner layer which is consist of 
tightly bound proteins that they don’t readily desorb, termed “hard corona” and an outer 
layer comprise the loosely bound proteins, referred as “soft corona”. Hard corona 
represents proteins with high affinity and low-abundance which are characterized by slow 
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exchange rate with the biological medium. In contrast, soft corona represents proteins with 
low affinity and high-abundance characterized by rapid exchange rate with the biological 
medium (Tenzer et al., 2013; Brun and Sicard–Roselli, 2014; Walkey et al., 2014; 
Westmeier et al., 2015; Zanganeh et al., 2016).  
 
Soft and hard corona can also be defined based on their residence time. Hard 
corona proteins have long residence time and they are more stable while soft corona 
proteins have short residence time and are more dynamic (Lynch and Dawson, 2008; 
Mahmoudi et al., 2011a; Hadjidemetriou et al., 2015). Due to their long lifetime on NP, 
hard corona resides on NP surface and undergo more biological process such as 
endocytosis. As such, hard corona plays more important role in determining the 
physiological response than soft corona (Nel et al., 2009; Walczyk et al., 2010). 
 
In a model proposed by Cedervall et al protein corona was distinguished as fast 
and slow components. Fast component was formed in seconds around NIPAM/BAM 
nanoparticles whereas slow component was adsorbed within hours. Desorption pattern 
also indicated the same trend with lifetime of roughly 10 minutes for the fast component 
and almost 8 hours for the slow component (Cedervall et al., 2007).  
 
It is hypothesized that proteins in hard corona, interact directly with the NP 
surface, while proteins of the soft corona interact with proteins of hard corona through 
weak protein– protein interactions (Walkey and Chan, 2012; Polyak and Cordovez, 2016). 
A model has been suggested by Simberg et al in which protein corona is composed of 
“primary binders” and “secondary binders”. The former directly recognize nanoparticles 
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surface while the latter interact with the primary binders. The activity of primary binders 
might be altered by secondary binders as they are masked, leading to avoid interaction of 
primary binders with the biological medium (Simberg et al., 2009). 
 
2.2.3 Biological consequences of protein-corona formation on nanoparticles 
Protein corona may affect numerous physiological responses such as toxicity, 
uptake, and biodistribution of nanoparticles. Formation of protein corona can be beneficial 
or disadvantageous in biomedical application of nanoparticles. Knowledge of implications 
of protein corona in clinical application of nanoparticles is of crucial importance to design 
the safe and applicable nanoparticles. Understanding the effect of protein corona on 
physiological responses enable preventing binding of certain proteins which stimulate 
phagocytosis and decrease blood circulation time of nanoparticle-based therapy. In the 
other hand, can make use of protein corona by designing nanoparticles to adsorb proteins 
of interest for targeting purpose which help directing of nanoparticle to the site of interest 
(Helou et al., 2013; Sobczynski et al., 2014; Lazarovits et al., 2015; Mirshafiee et al., 
2016b).  
 
Even though identical nanoparticles in different studies were applied, 
contradictory outcomes in cytotoxicity have been reported. Protein corona can affect 
toxicity profiles of nanoparticles in different ways. More specifically, protein corona may 
reduce NP-induced toxicities by acting as an interface in interactions with cell membrane 
and preventing cell membrane rupture (Corbo et al., 2016). In absence of protein corona, 
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NP interact with cell membrane proteins directly and disrupt the integrity of cell 
membrane leading to cell death (Ruenraroengsak et al., 2012; Wolfram et al., 2014). 
 
The impact of fetal bovine serum (FBS) driven protein corona on toxicity profile 
of Graphene Oxide (GO) nanosheets was evaluated. The cytotoxicity study at different 
concentration of FBS (1% and 10%) revealed that at low concentration (1%) cytotoxicity 
was in a concentration-dependent manner whereas by increasing serum concentration to 
10% the cytotoxicity of nanoparticles was highly reduced. Moreover, it was shown that 
the cytotoxicity of GO nanosheets occurred due to direct interaction of GO nanosheets 
with cell membrane thereby causing the cell membrane undergone sever damage (Hu et 
al., 2011b). 
 
Due to negative charge of cell membrane the role of protein corona in reduction 
of toxicity can be more significant when NP is positively charged (Molinaro et al., 2013; 
Wang et al., 2013). Protein corona of positively charged polystyrene NPs was retained on 
nanoparticles surface as were taken up by cells and trafficked to lysosomes. In this 
compartment, corona coated NPs was degraded and lysosomal content was released. 
Hence, protein corona protected the cell from any damage caused by bare NPs till it was 
cleared through lysosome (Wang et al., 2013). 
 
Toxicity of protein corona coated carbon nanotubes CNTs on human acute 
monocytic leukemia cell line (THP-1) and human umbilical vein endothelial cells 
(HUVECs) were examined by Ge et al.  It was found that protein corona significantly 
reduced toxicity of CNTs and as the density of adsorbed proteins increased, toxicity of 
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CNTs decreased (Ge et al., 2011). Tenzer and co-workers studied the effect of protein 
corona on toxicity and pathophysiology of nanoparticles. It was found that pristine silica 
NPs triggered thrombocytes activation and caused hemolysis. whereas, protein corona 
formed on silica NPs inhibited these adverse effects and protected the cells from damage 
(Tenzer et al., 2013). 
 
In addition to protecting cell membrane, formation of protein corona on 
nanoparticle increase their stability which in turn mitigate toxicity. This is prominent 
specially for those nanoparticles which are not stable like quantum dots and their 
degradation leads to release of toxic product (Corbo et al., 2016; Westmeier et al., 2016). 
Moreover, toxicity of NPs can be associated to formation of reactive oxygen species 
(ROS) when NPs have semiconductor features. In this case, formation of protein corona 
prevents generation of ROS and increase the safety of NPs (Manke et al., 2013; Minai et 
al., 2013). Cytotoxicity of cobalt oxide on human monocytic cell line (THP-1) was 
examined by Casals, 2011. It was observed that following incubation with serum, toxicity 
profile of cobalt oxide was remarkably reduced due to decrease in ROS generation (Casals 
et al., 2011). In another study, prior to exposure of ZnO NPs to human hepatocellular 
carcinoma (HepG2) cell, ZnO NPs pre incubated with cell culture medium. It was 
observed that the cytotoxicity of pre coated ZnO NPs were remarkably decreased to 
compare with pristine ZnO NPs. It was concluded that due to increase in amount and 
affinity of adsorbed proteins on NP surface, ROS formation as well as ZnO dissolution 




On the contrary, NP may cause denaturation in adsorbed proteins which can trigger 
toxicity. For instance, poly(acrylic) acid conjugated gold nanoparticles caused unfolding 
in the bound fibrinogen which in turn activated inflammatory signalling pathways result 
in release of inflammatory cytokines (Deng et al., 2011). The correlation between 
formation of protein corona and cellular uptake has been established. The nature of 
adsorbed plasma proteins is a determinant factor in degree and rate of cellular uptake 
(Laurent et al., 2013; Lee et al., 2015; Maiolo et al., 2015; Westmeier et al., 2015). More 
specifically, a subset of plasma proteins called “opsonin” which includes 
immunoglobulins and complement proteins enhance the cellular uptake while another 
subset of plasma protein referred as “dysopsonins” such as albumin lowers the uptake 
level (Owens and Peppas, 2006; Moghimi et al., 2011; Walkey and Chan, 2012). In some 
cases, protein corona diminishes nanoparticles adherence to the cell membrane result in 
reduction of uptake (Lesniak et al., 2012; Smith et al., 2012; Wolfram et al., 2014). 
 
The role of presence of protein corona on silica nanoparticles uptake by A549 lung 
epithelial cells was investigated. It was reported that the same nanoparticles show different 
biological responses depends on presence or absence of protein corona. In particular, in 
the absence of protein corona due to stronger adhesion of silica nanoparticles to the cell 
membrane higher internalization efficiency was observed (Lesniak et al., 2012). 
Oligonucleotide-functionalized gold nanoparticles (DNA-Au NPs or siRNA-Au NPs) 
were shown to have higher uptake in serum-free medium by HeLa cells. Pharmacological 
methods revealed that the serum proteins impaired the adhesion of nanoparticles to 




The uptake of dihydrolipoic acid-coated quantum dots (DHLA-QDs) by HeLa 
cells were studied by Treuel and co-workers. It was observed that following formation of 
protein corona on nanoparticles surface the uptake level has substantially deceased (Treuel 
et al., 2014). Using carboxyl functionalized Iron platinum (FePt NPs), it was shown that 
after exposure to human transferrin the uptake of these nanoparticles by HeLa cells was 
highly reduced (Jiang et al., 2010). Wang et al. investigated uptake of Gold nanoparticles 
(AuNPs, 20 nm) by mouse myogenic (Sol8) cells in presence and absence of protein 
corona. It was shown that presence of protein corona supress the nanoparticles to be taken 
up by mouse myogenic cells (Wang et al., 2012).  
 
On the contrary, some other researches indicated that protein corona facilitate 
uptake of particles by cells. The contradictory results may be due to different types of 
uptake that take place by cell such as specific or non-specific cellular uptake. Specific 
uptake is mediated by membrane receptors and have been reported to increase in presence 
of protein corona whereas, non-specific cellular uptake is regardless of cell receptors and 
is a random process which decrease with formation of protein corona (Brun and Sicard–
Roselli, 2014; Schöttler et al., 2016). The impact of presence of protein corona on degree 
of specific uptake was assessed by Krais, et al, 2014. Uptake study of folic acid-
functionalized iron oxide nanoparticles by ovarian cancer cells revealed that existence of 
protein corona is a requisite for uptake of nanoparticles (Krais et al., 2014). Using titanium 
dioxide (TiO2) nanoparticles, uptake of these particles by A549 and H1299 human lung 
cell lines after incubation with fetal bovine serum (FBS) were evaluated. It was shown 
that formation of protein corona increased the level and rate of nanoparticles uptake (Tedja 
et al., 2012a). 
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In addition, employing different cell lines in uptake studies may demonstrate 
contrasting results. While protein corona supress uptake of nanoparticles by monocytes 
due to blocking the surface of nanoparticle, some cells such as macrophages, neutrophils, 
and dendritic cells express receptors on their surface that enable them to interact with 
opsonins in protein corona result in triggering internalization (Karmali and Simberg, 2011; 
Goodridge et al., 2012; Wolfram et al., 2014; Corbo et al., 2016). Effect of different cell 
lines on uptake of nanoparticles in presence of protein corona was investigated by Yan et 
al. Uptake of disulfide-stabilized poly (methacrylic acid) nanoporous polymer particles 
(PMASH NPPs) by monocytes and macrophages was compared. Monocytic cells, THP-1 
internalized nanoparticles much fewer following formation of protein corona than bare 
nanoparticles. Uptake of nanoparticles by differentiated macrophage-like cells (dTHP-1) 
has shown an increment compared to bare nanoparticles due to trigger of scavenger 
receptors (Yan et al., 2013).  
 
2.3 Cellular uptake pathways of NPs  
Cell membrane (CM) employs different mechanisms to exchange substances 
which are mainly divided into two categories: passive transport and active transport. Gases 
such as oxygen and carbon dioxide, hydrophobic molecules such as benzene and 
uncharged molecules such as water and ethanol diffuse across the membrane from the 
regions of higher to lower concentration. This kind of transport which is along the 
concentration gradient and occurs without assistance of energy is called passive transport. 
In contrast, active transport occurs against the concentration gradient by using energy 
which is provided by adenosine triphosphate (ATP) (Feher, 2012; Backes, 2015; Douglas 
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et al., 2015). Polar or charged biomolecules that cannot pass through the hydrophobic 
plasma membrane are internalized by a form of active transport which is called 
endocytosis. In this process, the cell engulfs the materials inside the extracellular fluid by 
invagination of CM and buds off inside the cell, forming a membrane-bounded vesicle 
called an endosome (Makaraci and Kim, 2018).  
 
Endocytosis can be basically classified into two major categories: phagocytosis 
and pinocytosis. Phagocytosis (cell eating) is the process of taking in debris, bacteria or 
other large size solutes by specialized mammalian cells called phagocytes (i.e. monocytes, 
macrophages and neutrophils) (Nazario-Toole and Wu, 2017; Rajendran et al., 2018). 
Integral to phagocytosis is a process called opsonization by which opsonins such as 
immunoglobulins and complement proteins coat the target materials to trigger the 
phagocytes of their presence and to initialize phagocytic activity (Xiang et al., 2012). As 
the phagocyte begins to ingest the target material, it will simultaneously stimulate the 
formation of a membrane-bound vesicle called phagosome into which the ingested 
materials are compartmentalized within the phagocyte. At the latter stages of this process, 
the phagosome will fuse with the lysosome and the materials are digested at acidic pH by 
the hydrolytic enzymes contained within the lysosomal lumen (Hillaireau and Couvreur, 
2009; Xiang et al., 2012).  
 
In all cell types, small particles within the range of nanometers are internalized by 
pinocytosis (Zhao et al., 2011). In pinocytosis, “cellular drinking” plasma membrane 
